BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6806805)

  • 21. [Studies of the effect of antituberculosis agents against tubercle bacilli of the chronic tuberculosis in mice].
    Mabuchi H
    Bull Chest Dis Res Inst Kyoto Univ; 1980 Mar; 13(1-2):25-31. PubMed ID: 6821504
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy of tuberculosis for the 1980's.
    Dutt AK; Stead WW
    Clin Chest Med; 1980 May; 1(2):243-52. PubMed ID: 6794977
    [No Abstract]   [Full Text] [Related]  

  • 23. [Methods in the modern chemotherapy of tuberculosis (a lecture)].
    Khomenko AG
    Probl Tuberk; 1988; (8):53-7. PubMed ID: 3143997
    [No Abstract]   [Full Text] [Related]  

  • 24. [In vitro activities of antitubercular agents and intensification of combined chemotherapy of tuberculosis].
    Ooizumi K
    Kekkaku; 1983 Sep; 58(9):490-2. PubMed ID: 6420602
    [No Abstract]   [Full Text] [Related]  

  • 25. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
    Zunić D
    Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
    [No Abstract]   [Full Text] [Related]  

  • 26. Bacteriological bases of short-course chemotherapy.
    Grosset J
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):103-7. PubMed ID: 2999945
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
    Protsiuk RG
    Probl Tuberk; 1983 May; (5):38-42. PubMed ID: 6408637
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pathogenetic drugs in the treatment of destructive pulmonary tuberculosis in adolescents and adults].
    Buĭko RG; Maksimova NM
    Probl Tuberk; 1984 Jan; (1):45-9. PubMed ID: 6422459
    [No Abstract]   [Full Text] [Related]  

  • 29. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An evaluation of the results of the use of a short-duration chemotherapy regimen (3+3) in cases with tuberculosis of the respiratory tract in 1986].
    Didilescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):173-5. PubMed ID: 2555903
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of biological assay in the detection of "latent" bacteria release during chemotherapy].
    Posperov VV; Pashkov IuN; Lobchenko AI
    Probl Tuberk; 1982 Aug; (8):62-6. PubMed ID: 6815644
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study of tubercle bacilli from persistently sputum-positive patients treated with antituberculosis drugs for long duration in 3 Shanghai districts].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1983 Aug; 6(4):222-4. PubMed ID: 6418491
    [No Abstract]   [Full Text] [Related]  

  • 33. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
    Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096
    [No Abstract]   [Full Text] [Related]  

  • 34. [A study on the implementation of primary chemotherapy to pulmonary tuberculosis with positive bacillus].
    Tian XZ; Wang LX
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Aug; 16(4):220-2. PubMed ID: 7585902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long-term results of treatment of drug-resistant pulmonary tuberculosis in adolescents].
    Firsova VA; Poluĕktova FG; Ryzhova AP
    Probl Tuberk Bolezn Legk; 2005; (7):25-8. PubMed ID: 16130423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 38. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Morphologic and biochemical changes in Mycobacterium tuberculosis during chemotherapy].
    Khomenko AG; Fadeeva NI; Golyshevskaia VI
    Probl Tuberk; 1983 Jul; (7):48-54. PubMed ID: 6415652
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.